Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. BDB550853

HLA-DR, DP, DQ Mouse anti-Human, FITC, Clone: TÜ39, BD

Catalog No. BDB550853 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
50 Tests
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB550853 50 Tests
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB550853 Supplier BD Biosciences Supplier No. 550853
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Reacts with all major histocompatibility Class II HLA-DR, DP and most DQ antigens expressed on B cells, antigen presenting cells and activated T cells. This antibody fixes complement.

Host Species: Mouse
Clone: Tu39
Isotype: IgG2a κ
Species Reactivity: Human

Flow Cytometry

TRUSTED_SUSTAINABILITY

Specifications

Antigen HLA-DR, DP, DQ
Applications Flow Cytometry
Classification Monoclonal
Clone TÜ39
Conjugate FITC
Description Tü39
Formulation Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Host Species Mouse
Purification Method Affinity Purified
Quantity 50 Tests
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Target Species Baboon, Cynomolgus, Rhesus Monkey
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Isotype IgG2a κ
Show More Show Less

For Research Use Only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.